Maximizing the use of the progestin minipill.
D000569:Americas; D001695:Biology; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D019049:Developed Countries; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D007774:Lactation; D009656:North America; D010827:Physiology; D011247:Pregnancy; D045167:Progesterone Congeners; D014481:United States
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D045167:Progesterone Congeners
Americas; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Contraceptive Methods Chosen; Contraceptive Usage; Critique; Developed Countries; Family Planning; Lactation; Maternal Physiology; North America; Northern America; Oral Contraceptives; Oral Contraceptives, Low-dose; Physiology; Progestins, Low-dose; United States